Anne Olson - Jan 1, 2023 Form 4 Insider Report for CENTERSPACE (CSR)

Role: COO, Gen Counsel and Secretary
Signature: Anne Olson
Stock symbol: CSR
Transactions as of: Jan 1, 2023
Transactions value $: $636,217
Form type: 4
Date filed: 1/4/2023, 02:01 PM
Previous filing: May 4, 2022
Next filing: Mar 15, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CSR	Common Shares of Beneficial Interest	Options Exercise	$0	+540	+3.83%	$0.00	14.6K	Jan 1, 2023	Direct
transaction	CSR	Common Shares of Beneficial Interest	Options Exercise	$0	+373	+2.55%	$0.00	15K	Jan 1, 2023	Direct
transaction	CSR	Common Shares of Beneficial Interest	Tax liability	-$26.4K	-450	-3%	$58.67	14.6K	Jan 1, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CSR	Restricted Stock Units	Award	$0	+3.02K		$0.00	3.02K	Jan 1, 2023	Common Shares of Beneficial Interest	3.02K	$0.00	Direct	F2
transaction	CSR	Stock Options (Right to Buy)	Award	$663K	+11.3K		$58.67	11.3K	Jan 1, 2023	Common Shares of Beneficial Interest	11.3K	$58.67	Direct	F3
transaction	CSR	Restricted Stock Units	Options Exercise	$0	-540	-50%	$0.00	540	Jan 1, 2023	Common Shares of Beneficial Interest	540	$0.00	Direct
transaction	CSR	Restricted Stock Units	Options Exercise	$0	-373	-33.27%	$0.00	748	Jan 1, 2023	Common Shares of Beneficial Interest	373	$0.00	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares withheld for payment of taxes in connection with the vesting of restricted stock units.
F2	Represents a time-based contingent right to receive 3,022 common shares of beneficial interest of Centerspace vesting over three years in one-third increments on each anniversary of the grant date: January 1, 2024, 2025 and 2026.
F3	Represents the right to purchase 11,294 common shares of beneficial interest of Centerspace, vesting over four years in one-fourth increments on each anniversary of the grant date: January 1, 2024, 2025, 2026 and 2027.